DNA vaccines

Intervirology

Volumn 42, Issue 2-3, 1999, Pages 117-124

  Encke, Jens ^a   Zu Putlitz, Jasper ^a   Wands, Jack R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Genetic immunization; Hepatitis B virus; Hepatitis C virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; STRUCTURAL PROTEIN; VIRUS VACCINE;

ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CHRONIC LIVER DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODY FORMATION; HEPACIVIRUS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; MICE; T-LYMPHOCYTES; VACCINES, DNA; VIRAL VACCINES;

EID: 0032854018     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024971     Document Type: Review

References (78)

1. Hadler SC, Margolis HS: Epidemiology of hepatitis B virus infection; in Ellis RW (ed): Hepatitis B Vaccines in Clinical Practice. New York, Dekker, 1993, pp 323-336.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-home non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
3. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, et al: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team [see comments]. N Engl J Med 1992;327: 1899-1905.
4. Heintges T, Wands JR: Hepatitis C virus: Epidemiology and transmission. Hepatology 1997; 26:521-526.
5. Lemon SM, Thomas DL: Vaccines to prevent viral hepatitis. N Engl J Med 1997;336:196-204.
6. Hoofnagle JH, Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 1997; 336:347-356.
7. Carithers RL Jr, Emerson SS: Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials. Hepatology 1997;26:83S-88S.
8. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR: Human hepatitis B vaccine from recombinant yeast. Nature 1984;307:178-180.
9. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE: Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995;171:S44-S49.
10. Davis HL, Brazolot Millan CL: DNA-based immunization against hepatitis B virus. Springer Semin Immunopathol 1997;19:195-209.
11. Inchauspe G: Gene vaccination for hepatitis C. Springer Semin Immunopathol 1997;19:211-221.
12. Koziel MJ, Liang TJ: DNA vaccines and viral hepatitis: Are we going around in circles? [editorial: comment] [see comments]. Gastroenterology 1997;112:1410-1414.
13. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL: Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-1468.
14. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkoski SH, Deck RR, De Witt CM, Friedman A, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-1749.
15. McDonnell WM, Askari FK: Immunization. JAMA 1997;278:2000-2007.
16. Corr M, Tighe H: Plasmid DNA vaccination: Mechanism of antigen presentation. Springer Semin Immunopathol 1997;19:139-145.
17. McDonnell WM, Askari FK: DNA vaccines. N Engl J Med 1996;334:42-45.
18. Davis HL, Michel ML, Whalen RG: Use of plasmid DNA for direct gene transfer and immunization. Ann NY Acad Sci 1995;772:21-29.
19. Bohm W, Mertens T, Schirmbeck R, Reinmann J: Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 1998;16:949-954.
20. Gramzinski RA, Millan CL, Obaldia N, Hoffman SL, Davis HL: Immune response to a hepatitis B DNA vaccine in Aotus monkeys: A comparison of vaccine formulation, route, and method of administration. Mol Med 1998;4: 109-118.
21. Gregoriadis G, Saffie R, de Souza JB: Liposome-niediated DNA vaccination. FEBS Lett 1997;402:107-110.
22. Bohm W, Kuhrober A, Paier T, Mertens T, Reimann J, Schirmbeck R: DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J Immunol Methods 1996;193:29-40.
23. Mancini M, Davis H, Tiollais P, Michel ML: DNA-based immunization against the envelope proteins of the hepatitis B virus. J Biotechnol 1996;44:47-57.
24. Geissler M, Gesien A, Tokushige K, Wands JR: Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 1997; 158:1231-1237.
25. Geissler M, Schirmbeck R, Reimann J, Blum HE, Wands JR: Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 1998;28:202-210.
26. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH: Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997; 71:169-178.
27. Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT, Tao MH: Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998;160:1320-1329.
28. Xiang Z, Ertl HC: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995;2:129-135.
29. Raz E: Introduction: Gene vaccination, current concepts and future directions. Springer Semin Immunopathol 1997;19:131-137.
30. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA: Preclinital efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nat Med 1995; 1:583-587.
31. Fuller DH, Corb MM, Barnett S, Steimer K, Haynes JR: Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 1997; 15:924-926.
32. Fuller JT, Fuller DH, McCabe D, Haynes JR, Widera G: Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization. Ann NY Acad Sci 1995; 772:282-284.
33. Chattergoon M, Boyer J, Weiner DB: Genetic immunization: A new era in vaccines and immune therapeutics. FASEB J 1997;11:753-763.
34. Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments]. Nat Med 1997;3:526-532.
35. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, De Witt CM, Orme IM, Baldwin S, D'Souza C, Drowart A, Lozes E, Vandenbussche P, Van Vooren JP, Liu MA, Ulmer JB: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996;2:893-898.
36. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB: Vaccination against tuberculosis by DNA injection. Nat Med 1996;2:888-892.
37. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV: Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996;70: 7092-7102.
38. Chisari FV: Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-1477.
39. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG: DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 1995;92:5307-5311.
40. Davis HL, Michel ML, Mancini M, Schleef M, Whalen RG: Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994;12:1503-1509.
41. Davis HL, Schirmbeck R, Reimann J, Whalen RG: DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 1995;6:1447-1456.
42. Davis HL, Mancini M, Michel ML, Whalen RG: DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine 1996;14: 910-915.
43. Whalen RG, Leclerc C, Deriaud E, Schirmbeck R. Reimann J, Davis HL: DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann NY Acad Sci 1995;772:64-76.
44. Geissler M, Tokushige K, Chante CC, Zurawski VR, Wands JR: Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 1997;112:1307-1320.
45. Sallherg M, Townsend K, Chen M, O'Dea J, Banks T, Jolly DJ, Chang SM, Lee WT, Milich DR: Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens. J Virol 1997;71:5295-5303.
46. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trepo C, Inchauspe G: DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995;69: 5798-5805.
47. Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J: Nucleic acid vaccination primes hepatitis B virus surface antigen specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995;69:5929-5934.
48. Kuhrober A, Wild J, Pudollek HP, Chisari FV, Reimann J: DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb-and Kd-restricted epitopes. Int Immunol 1997;9:1203-1212.
49. Kuhober A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R: DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J Immunol 1996;156:3687-3695.
50. Davis HL, Michel ML, Whalen RG: DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993;2:1847-1851.
51. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM: CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998;160:870-876.
52. Leclerc C, Deriaud E, Rojas M, Whalen RG: The preferential induction of a ThI immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol 1997;179:97-106.
53. McCluskie MJ, Davis HL: CpG DNA is a potent enhancer of systemic and mucosal immune response against hepatitis B surface antigen with intranasal administration to mice. J Immunol 1998;161:4463-4466.
54. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel ML: DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 1996;93:12496-12501.
55. Shimizu Y, Guidotti LC, Fowler P, Chisari FV: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998;161:4520-4529.
56. Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ: Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J Virol 1998;72:84-94.
57. Rollier C, Sunyach C, Barraud L, Madani N, Jamard C, Trepo C, Cova L: Effect of naked DNA immunization on chronic DHBV infection; pers commun, 1998.
58. Davis HL, McCluskie MJ, Gerin JL, Purcell RH: DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 1996;93:7213-7218.
59. Prince AM, Whalen R, Brotman B: Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine 1997;15:916-919.
60. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY: The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:1473-1481.
61. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV: Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98:1432-1440.
62. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR: Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
63. Misaale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-714.
64. Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R: Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 1995;69:5859-5863.
65. Saito T, Sherman GJ, Kurokohchi K, Guo ZP, Donets M, Yu MY, Berzofsky JA, Akatsuka T, Feinstone SM: Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice. Gastroenterology 1997;112:1321-1330.
66. Tokushige K, Wakita T, Pachuk C, Moradpour, Weiner DB, Zurawski VR Jr, Wands JR: Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 1996;24:14-20.
67. Inchauspe G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C: Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 1997;16:185-195.
68. Inchauspe G, Major ME, Nakano I, Vitvitski L, Trepo C: DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 1997;15:853-856.
69. Geissler M, Gesien A, Wands JR: Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J Immunol 1997;159:5107-5113.
70. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H: Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.
71. Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J, Fournillier A, De Martynoff G, Trepo C, Inchauspe G: Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol 1997;71:7101-7109.
72. Tedeschi V, Akatsuka T, Shin JW, Battegay M, Feinstone SM: A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology 1997;25:459-462.
73. Encke J, zu Putlitz J, Geissler M, Wands JR: Genetic immunization generates cellular and humoral immune responses against the non-structural proteins of the hepatitis C virus in a murine model. J Immunol 1998;161:4917-4923.
74. Ulrich R, Gerlich WH, Kruger DH: Chimaera and its modern virus-like descendants. Intervirology 1996;39:126-132.
75. Geissler M, Tokushige K, Wakita T, Zurawski VR, Wands JR: Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimcric constructs. Vaccine 1998;16:857-867.
76. Le Borgne S, Mancini M, Le Grand R, Schleef M, Dormont D, Tiollais P, Riviere Y, Michel ML: In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 1998;240:304-315.
77. He J, Hoffman SL, Hayes CG: DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 1997;15:357-362.
78. Lu F, Zhuang H, Zhu Y, Zhu X: A preliminary study on immune response to hepatitis E virus DNA vaccine in mice. Chin Med J (Engl) 1996; 109:919-921.